Largest Pharmaceutical Stocks
The biggest pharmaceutical preparation companies, with dividend yields where paid.
| # | Company | Price | Change | Dividend Yield | Market Cap |
|---|---|---|---|---|---|
| 1 | LLYEli Lilly & Co. | $1437.29 | ▲ 0.35% | 0.48% | $1.28 trillion |
| 2 | JNJJohnson & Johnson | $283.11 | ▲ 0.96% | 1.89% | $675.03 billion |
| 3 | ABBVABBVIE INC. | $294.98 | ▲ 0.37% | 2.47% | $521.41 billion |
| 4 | ABTAbbott Laboratories | $109.29 | ▼ 1.06% | 2.31% | $189.28 billion |
| 5 | PFEPfizer Inc. | $29.36 | ▲ 0.44% | 5.86% | $167.35 billion |
| 6 | BMYBristol-Myers Squibb Co. | $62.80 | ▲ 1.06% | 4.01% | $128.37 billion |
| 7 | REGNRegeneron Pharmaceuticals Inc | $959.41 | ▲ 4.73% | 0.39% | $94.76 billion |
| 8 | RPRXRoyalty Pharma plc Class A Ordinary Shares | $69.45 | ▲ 0.99% | 1.35% | $30.92 billion |
| 9 | ROIVRoivant Sciences Ltd. Common Shares | $39.99 | ▼ 4.44% | — | $30.32 billion |
| 10 | INSMInsmed, Inc. | $114.42 | ▲ 0.01% | — | $25.10 billion |
| 11 | UTHRUnited Therapeutics Corp | $582.46 | ▲ 3.64% | — | $23.94 billion |
| 12 | VTRSViatris Inc. Common Stock | $19.91 | ▲ 4.96% | 2.41% | $21.79 billion |
| 13 | ALNYAlnylam Pharmaceuticals, Inc. | $157.87 | ▼ 1.24% | — | $21.41 billion |
| 14 | SMMTSummit Therapeutics Inc. Common Stock | $17.83 | ▼ 0.06% | — | $14.26 billion |
| 15 | ELANElanco Animal Health Incorporated Common Stock | $27.01 | ▲ 2.00% | — | $13.24 billion |
| 16 | BMRNBioMarin Pharmaceuticals Inc | $56.12 | ▼ 1.77% | — | $10.87 billion |
| 17 | SYRESpyre Therapeutics, Inc. Common Stock | $109.00 | ▲ 4.95% | — | $9.86 billion |
| 18 | TGTXTG Therapeutics, Inc. | $63.41 | ▲ 5.99% | — | $9.16 billion |
| 19 | PTGXProtagonist Therapeutics, Inc | $135.90 | ▲ 2.92% | — | $8.87 billion |
| 20 | CORTCorcept Therapeutics Inc. | $75.86 | ▲ 1.12% | — | $8.11 billion |
| 21 | RYTMRhythm Pharmaceuticals, Inc. Common Stock | $112.16 | ▼ 1.57% | — | $7.90 billion |
| 22 | KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $96.28 | ▲ 0.54% | — | $7.52 billion |
| 23 | PRAXPraxis Precision Medicines, Inc. Common Stock | $262.59 | ▼ 7.80% | — | $7.33 billion |
| 24 | AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock | $19.45 | ▼ 2.51% | — | $6.95 billion |
| 25 | ARWRArrowhead Research Corporation | $49.36 | ▲ 0.73% | — | $6.92 billion |
| 26 | MANEVeradermics, Incorporated | $135.29 | ▼ 13.59% | — | $6.61 billion |
| 27 | ORKAOruka Therapeutics, Inc. Common Stock | $96.87 | ▲ 0.23% | — | $6.40 billion |
| 28 | MIRMMirum Pharmaceuticals, Inc. Common Stock | $93.18 | ▼ 0.58% | — | $6.08 billion |
| 29 | PTCTPTC Therapeutics, Inc. | $68.97 | ▲ 1.25% | — | $5.69 billion |
| 30 | ERASErasca, Inc. Common Stock | $15.29 | ▼ 2.02% | — | $5.46 billion |
| 31 | TVTXTravere Therapeutics, Inc. Common Stock | $51.00 | ▼ 1.90% | — | $4.99 billion |
| 32 | LQDALiquidia Corporation Common Stock | $47.87 | ▲ 7.82% | — | $4.28 billion |
| 33 | ABCLAbCellera Biologics Inc. Common Shares | $12.20 | ▼ 2.44% | — | $4.05 billion |
| 34 | ARQTArcutis Biotherapeutics, Inc. Common Stock | $32.07 | ▲ 0.31% | — | $4.03 billion |
| 35 | TNGXTango Therapeutics, Inc. | $20.87 | ▼ 9.97% | — | $3.91 billion |
| 36 | XENEXenon Pharmaceuticals Inc | $40.45 | ▲ 3.27% | — | $3.79 billion |
| 37 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | $29.50 | ▲ 6.81% | 5.69% | $3.79 billion |
| 38 | IRONDisc Medicine, Inc. Common Stock | $82.84 | ▼ 0.43% | — | $3.69 billion |
| 39 | ACADAcadia Pharmaceuticals Inc. | $16.50 | ▼ 22.28% | — | $3.67 billion |
| 40 | PBLSParabilis Medicines, Inc. Common Stock | $29.65 | ▼ 1.23% | — | $3.66 billion |
| 41 | VKTXViking Therapeutics, Inc | $27.58 | ▼ 3.02% | — | $3.63 billion |
| 42 | DYNDyne Therapeutics, Inc. Common Stock | $17.92 | ▼ 3.76% | — | $3.49 billion |
| 43 | VRDNViridian Therapeutics, Inc. Common Stock | $28.49 | ▼ 0.21% | — | $3.24 billion |
| 44 | BHCBausch Health Companies Inc | $8.35 | ▲ 0.72% | — | $3.10 billion |
| 45 | IDYAIDEAYA Biosciences, Inc. Common Stock | $31.75 | ▼ 0.87% | — | $3.10 billion |
| 46 | XNCRXencor, Inc. | $38.13 | ▼ 4.60% | — | $3.00 billion |
| 47 | ZLABZai Lab Limited American Depositary Shares | $22.94 | ▲ 4.46% | — | $2.73 billion |
| 48 | RCUSArcus Biosciences, Inc. | $18.95 | ▲ 3.67% | — | $2.63 billion |
| 49 | NAMSNewAmsterdam Pharma Company N.V. Ordinary Shares | $19.79 | ▼ 4.49% | — | $2.48 billion |
| 50 | PRGOPERRIGO COMPANY PLC | $16.83 | ▼ 0.71% | 6.89% | $2.34 billion |
Rankings reflect our cached coverage universe and delayed fundamental data. For informational purposes only — not investment advice.